{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:35:32Z","timestamp":1787596532813,"version":"build-2736575974"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/aci.0000000000000009","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T12:41:06Z","timestamp":1381754466000},"page":"639-645","source":"Crossref","is-referenced-by-count":21,"title":["B-cell memory and primary immune deficiencies"],"prefix":"10.1097","volume":"13","author":[{"given":"Marylin","family":"Desjardins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Mazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210128","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients.","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"key":"R2-8-20210128","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jaci.2013.01.046","article-title":"B-cell biology and development.","volume":"131","author":"Pieper","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"R3-8-20210128","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.iac.2008.01.001","article-title":"Common variable immunodeficiency: an update on etiology and management.","volume":"28","author":"Yong","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"R4-8-20210128","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jaci.2010.02.018","article-title":"Clinical consequences of defects in B-cell development.","volume":"125","author":"Vale","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R5-8-20210128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/cyto.b.20432","article-title":"Flowcytometric phenotyping of common variable immunodeficiency.","volume":"74B","author":"Warnatz","year":"2008","journal-title":"Clin Cytometry"},{"key":"R6-8-20210128","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency.","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"R7-8-20210128","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1077002","article-title":"A critical role for IL-21 in regulating immunoglobulin production.","volume":"298","author":"Ozaki","year":"2002","journal-title":"Science"},{"key":"R8-8-20210128","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1182\/blood-2011-06-362533","article-title":"IL-21 is the primary common y chain-binding cytokine required for human B-cell differentiation in vivo.","volume":"118","author":"Recher","year":"2011","journal-title":"Blood"},{"key":"R9-8-20210128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/35040504","article-title":"Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte fonction.","volume":"408","author":"Parrish-Novak","year":"2000","journal-title":"Nature"},{"key":"R10-8-20210128","doi-asserted-by":"crossref","first-page":"11439","DOI":"10.1073\/pnas.200360997","article-title":"Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain.","volume":"97","author":"Ozaki","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R11-8-20210128","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1084\/jem.20111229","article-title":"Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome.","volume":"210","author":"Kotlarz","year":"2013","journal-title":"J Exp Med"},{"key":"R12-8-20210128","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.0105-2896.2004.00201.x","article-title":"Biology of IL-21 and the IL-21 receptor.","volume":"202","author":"Metha","year":"2004","journal-title":"Immunol Rev"},{"key":"R13-8-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.167.1.1","article-title":"Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex.","volume":"167","author":"Asao","year":"2001","journal-title":"J Immunol"},{"key":"R14-8-20210128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1084\/jem.20091706","article-title":"B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans.","volume":"207","author":"Avery","year":"2010","journal-title":"J Exp Med"},{"key":"R15-8-20210128","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4049\/jimmunol.173.1.657","article-title":"Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis.","volume":"173","author":"Jin","year":"2004","journal-title":"J Immunol"},{"key":"R16-8-20210128","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.4161\/onci.22354","article-title":"Why do human B cells secrete granzyme B O","volume":"1","author":"Hagn","year":"2012","journal-title":"ncoimmunology"},{"key":"R17-8-20210128","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.4049\/jimmunol.0901066","article-title":"Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21.","volume":"183","author":"Hagn","year":"2009","journal-title":"J Immunol"},{"key":"R18-8-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/icb.2011.64","article-title":"Human B cells differentiate into granzyme B-secreting cytotoxic B lymphocytes upon incomplete T-cell help.","volume":"90","author":"Hagn","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"R19-8-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellimm.2011.01.004","article-title":"B cells from common variable immunodeficiency patients fail to differentiate to antibody secreting cells in response to TLR9 ligand (CpG-ODN) or anti-CD40 IL21.","volume":"268","author":"Clemente","year":"2011","journal-title":"Cell Immunol"},{"key":"R20-8-20210128","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.4049\/jimmunol.175.12.7867","article-title":"IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells.","volume":"175","author":"Ettinger","year":"2005","journal-title":"J Immunol"},{"key":"R21-8-20210128","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4049\/jimmunol.170.2.686","article-title":"Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses.","volume":"170","author":"Tangye","year":"2003","journal-title":"J Immunol"},{"key":"R22-8-20210128","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.4049\/jimmunol.179.12.8180","article-title":"Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5 T follicular helper cells.","volume":"179","author":"Bryant","year":"2007","journal-title":"J Immunol"},{"key":"R23-8-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2012.00002","article-title":"The interplay of IL-21 and BAFF in the formation and maintenance of human B cell memory.","volume":"3","author":"Karnell","year":"2012","journal-title":"Front Immunol"},{"key":"R24-8-20210128","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome.","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"key":"R25-8-20210128","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in DNA-binding domain of STAT3 cause hyper-IgE syndrome.","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"R26-8-20210128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaci.2008.04.037","article-title":"Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced TH17 cells numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.","volume":"122","author":"Renner","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"R27-8-20210128","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/0091-6749(88)90873-1","article-title":"Impaired antibody responses in the hyperimmunoglobulin E syndrome.","volume":"81","author":"Leung","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"R28-8-20210128","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/ni829","article-title":"DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL.","volume":"3","author":"Litinskiy","year":"2002","journal-title":"Nat Immunol"},{"key":"R29-8-20210128","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4049\/jimmunol.181.1.276","article-title":"Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF.","volume":"181","author":"Xu","year":"2008","journal-title":"J Immunol"},{"key":"R30-8-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.immuni.2006.12.006","article-title":"Unique maturation program of the IgE response in vivo.","volume":"26","author":"Erazo","year":"2007","journal-title":"Immunity"},{"key":"R31-8-20210128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1067\/mai.2000.107935","article-title":"An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German Multicenter Atopy Study (MAS-90).","volume":"106","author":"Liu","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"R32-8-20210128","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1084\/jem.20111155","article-title":"Immature B cells preferentially switch to IgE with increased direct Smu to Sepsilon recombination.","volume":"208","author":"Wesemann","year":"2011","journal-title":"JEM"},{"key":"R33-8-20210128","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jpeds.2009.07.049","article-title":"Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or posttransplant GVHD prophylaxis.","volume":"155","author":"Railey","year":"2009","journal-title":"J Pediatr"},{"key":"R34-8-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12026-010-8191-9","article-title":"Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.","volume":"49","author":"Buckley","year":"2011","journal-title":"Immunol Res"},{"key":"R35-8-20210128","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/MPG.0b013e318054b09b","article-title":"Cryptosporidium infection in patients with primary immunodeficiencies.","volume":"45","author":"Wolska-Kusnierz","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R36-8-20210128","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature05969","article-title":"Essential autocrine regulation by IL-21 in the generation of inflammatory T cells.","volume":"448","author":"Nurieva","year":"2007","journal-title":"Nature"},{"key":"R37-8-20210128","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1586\/eci.09.43","article-title":"Role of B cells in common variable immune deficiency.","volume":"5","author":"Ahn","year":"2009","journal-title":"Expert Rev Clin Immunol"},{"key":"R38-8-20210128","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(08)61199-X","article-title":"Common variable immunodeficiency: a new look at an old disease.","volume":"372","author":"Park","year":"2008","journal-title":"Lancet"},{"key":"R39-8-20210128","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/MOP.0b013e3282f1ddd5","article-title":"Common variable immunodeficiency in children.","volume":"19","author":"Glocker","year":"2007","journal-title":"Curr Opin Pediatr"},{"key":"R40-8-20210128","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jaci.2006.01.038","article-title":"Molecular basis of common variable immunodeficiency.","volume":"117","author":"Castigli","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"R41-8-20210128","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27()IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"key":"R42-8-20210128","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1025373601374","article-title":"Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.","volume":"23","author":"Piqueras","year":"2003","journal-title":"J Clin Immunol"},{"key":"R43-8-20210128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2172-9-3","article-title":"Screening of functional and positional candidate genes in families with common variable immunodeficiency.","volume":"9","author":"Salzer","year":"2008","journal-title":"BMC Immunol"},{"key":"R44-8-20210128","doi-asserted-by":"crossref","first-page":"AB70","DOI":"10.1016\/j.jaci.2012.12.914","article-title":"Impaired in vitro capacity to undergo IgG isotype class-switching (ICS) in response to interleukin-21 (IL21) stimulation in common variable immunodeficiency (CVID).","volume":"131","author":"Desjardins","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"R45-8-20210128","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1182\/blood-2009-02-207423","article-title":"Interleukin-21 restores immunoglobulin production ex vivo in patients with common variable immunodeficiency and selective IgA deficiency.","volume":"114","author":"Borte","year":"2009","journal-title":"Blood"},{"key":"R46-8-20210128","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1182\/blood-2011-10-388546","article-title":"IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis.","volume":"119","author":"Attridge","year":"2012","journal-title":"Blood"},{"key":"R47-8-20210128","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3899\/jrheum.120468","article-title":"Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus.","volume":"39","author":"Terrier","year":"2012","journal-title":"J Rheumatol"},{"key":"R48-8-20210128","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2011.05.029","article-title":"Critical role of IL-21 in modulating TH17 and regulatory T cells in Behcet disease.","volume":"128","author":"Geri","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R49-8-20210128","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.4238\/2011.October.31.6","article-title":"Association between interleukin 21 and Graves disease.","volume":"10","author":"Jia","year":"2011","journal-title":"Genet Mol Res"},{"key":"R50-8-20210128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4161\/mabs.4.1.18713","article-title":"Generation and characterization of human antihuman IL-21 neutralizing monoclonal antibodies.","volume":"4","author":"Maurer","year":"2012","journal-title":"MABs"},{"key":"R51-8-20210128","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/bjc.2011.599","article-title":"A phase I trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer.","volume":"106","author":"Steele","year":"2012","journal-title":"Br J Cancer"},{"key":"R52-8-20210128","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1158\/1078-0432.CCR-12-0456","article-title":"A phase I dose-finding trial of recombinant interleukin-21 and rituximab in relapsed and refractory low grade B-cell lymphoproliferative disorders.","volume":"18","author":"Timmerman","year":"2012","journal-title":"Clin Cancer Res"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0000000000000009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T16:40:48Z","timestamp":1636562448000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130832-201312000-00008"}},"subtitle":["interleukin-21 related defects"],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0000000000000009","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}